BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32539808)

  • 21. Disease Evolution Monitored by Serial Cerebrospinal Fluid Liquid Biopsies in Two Cases of Recurrent Medulloblastoma.
    O'Halloran K; Margol A; Davidson TB; Estrine D; Tamrazi B; Cotter JA; Ji J; Biegel JA
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study.
    Rajagopal MU; Hathout Y; MacDonald TJ; Kieran MW; Gururangan S; Blaney SM; Phillips P; Packer R; Gordish-Dressman H; Rood BR
    Proteomics; 2011 Mar; 11(5):935-43. PubMed ID: 21271676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Classification of Medullobastomas by Whole Genome Expression Profiling.
    Nosková H; Adamcová S; Knoflíčková LDR; Pavelka Z; Vejmělková K; Zitterbart K; Slabý O; Štěrba J
    Klin Onkol; 2019; 32(Supplementum1):171-173. PubMed ID: 31064192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in cerebrospinal fluid protein concentration in children following surgery for cerebellar medulloblastoma].
    Adamczyk A; Wyszkowski J; Kaciński M
    Neurol Neurochir Pol; 1978; 12(4):443-50. PubMed ID: 714224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma.
    Escudero L; Llort A; Arias A; Diaz-Navarro A; Martínez-Ricarte F; Rubio-Perez C; Mayor R; Caratù G; Martínez-Sáez E; Vázquez-Méndez É; Lesende-Rodríguez I; Hladun R; Gros L; Ramón Y Cajal S; Poca MA; Puente XS; Sahuquillo J; Gallego S; Seoane J
    Nat Commun; 2020 Oct; 11(1):5376. PubMed ID: 33110059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes.
    Sharma T; Schwalbe EC; Williamson D; Sill M; Hovestadt V; Mynarek M; Rutkowski S; Robinson GW; Gajjar A; Cavalli F; Ramaswamy V; Taylor MD; Lindsey JC; Hill RM; Jäger N; Korshunov A; Hicks D; Bailey S; Kool M; Chavez L; Northcott PA; Pfister SM; Clifford SC
    Acta Neuropathol; 2019 Aug; 138(2):309-326. PubMed ID: 31076851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescence Lifetime Imaging Microscopy, a Novel Diagnostic Tool for Metastatic Cell Detection in the Cerebrospinal Fluid of Children with Medulloblastoma.
    Gershanov S; Michowiz S; Toledano H; Yahav G; Barinfeld O; Hirshberg A; Ben-Zvi H; Mircus G; Salmon-Divon M; Fixler D; Goldenberg-Cohen N
    Sci Rep; 2017 Jun; 7(1):3648. PubMed ID: 28623325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
    Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
    J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of tumor location and fourth ventricle infiltration in medulloblastoma.
    Jiang T; Zhang Y; Wang J; Du J; Ma Z; Li C; Liu R; Zhang Y
    Acta Neurochir (Wien); 2016 Jun; 158(6):1187-95. PubMed ID: 27106847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular biology of medulloblastoma metastasis.
    Van Ommeren R; Garzia L; Holgado BL; Ramaswamy V; Taylor MD
    Brain Pathol; 2020 May; 30(3):691-702. PubMed ID: 31883407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Embryonal brain tumor with unknown primary lesion and massive cerebrospinal fluid dissemination: A case report.
    Tanaka H; Yamamoto D; Ikeda M; Morikawa M; Ueda K; Tanaka K; Sasayama T; Kohmura E
    J Clin Neurosci; 2018 Aug; 54():125-128. PubMed ID: 29843922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma.
    Donovan LK; Delaidelli A; Joseph SK; Bielamowicz K; Fousek K; Holgado BL; Manno A; Srikanthan D; Gad AZ; Van Ommeren R; Przelicki D; Richman C; Ramaswamy V; Daniels C; Pallota JG; Douglas T; Joynt ACM; Haapasalo J; Nor C; Vladoiu MC; Kuzan-Fischer CM; Garzia L; Mack SC; Varadharajan S; Baker ML; Hendrikse L; Ly M; Kharas K; Balin P; Wu X; Qin L; Huang N; Stucklin AG; Morrissy AS; Cavalli FMG; Luu B; Suarez R; De Antonellis P; Michealraj A; Rastan A; Hegde M; Komosa M; Sirbu O; Kumar SA; Abdullaev Z; Faria CC; Yip S; Hukin J; Tabori U; Hawkins C; Aldape K; Daugaard M; Maris JM; Sorensen PH; Ahmed N; Taylor MD
    Nat Med; 2020 May; 26(5):720-731. PubMed ID: 32341580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous seeding of medulloblastoma: results of cerebrospinal fluid cytology and arachnoid biopsy from the cisterna magna.
    Tomita T; McLone DG
    Neurosurgery; 1983 Mar; 12(3):265-7. PubMed ID: 6843796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.
    Korshunov A; Okonechnikov K; Stichel D; Schrimpf D; Delaidelli A; Tonn S; Mynarek M; Sievers P; Sahm F; Jones DTW; von Deimling A; Pfister SM; Kool M
    Acta Neuropathol; 2022 Aug; 144(2):339-352. PubMed ID: 35771282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs.
    Lee B; Mahmud I; Pokhrel R; Murad R; Yuan M; Stapleton S; Bettegowda C; Jallo G; Eberhart CG; Garrett T; Perera RJ
    Acta Neuropathol Commun; 2022 Feb; 10(1):25. PubMed ID: 35209946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging spectrum of medulloblastoma.
    Fruehwald-Pallamar J; Puchner SB; Rossi A; Garre ML; Cama A; Koelblinger C; Osborn AG; Thurnher MM
    Neuroradiology; 2011 Jun; 53(6):387-96. PubMed ID: 21279509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
    Grotzer MA; von Hoff K; von Bueren AO; Shalaby T; Hartmann W; Warmuth-Metz M; Emser A; Kortmann RD; Kuehl J; Pietsch T; Rutkowski S
    Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II study of radioimmunotherapy with intraventricular
    Kramer K; Pandit-Taskar N; Humm JL; Zanzonico PB; Haque S; Dunkel IJ; Wolden SL; Donzelli M; Goldman DA; Lewis JS; Lyashchenko SK; Khakoo Y; Carrasquillo JA; Souweidane MM; Greenfield JP; Lyden D; De Braganca KD; Gilheeney SW; Larson SM; Cheung NV
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28940863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor.
    Fouladi M; Gajjar A; Boyett JM; Walter AW; Thompson SJ; Merchant TE; Jenkins JJ; Langston JW; Liu A; Kun LE; Heideman RL
    J Clin Oncol; 1999 Oct; 17(10):3234-7. PubMed ID: 10506624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extraneural metastatic medulloblastoma during childhood.
    McComb JG; Davis RL; Isaacs H
    Neurosurgery; 1981 Nov; 9(5):548-51. PubMed ID: 7322317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.